Medicure Inc. (MPH) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and welcome to Medicare's earnings conference call for the year ended December 2025. My name is Ali and I will be your operator for today's call. At this time, all participants are in listen-only mode. Before we proceed, I would like to remind everyone that this presentation contains forward-looking statements relating to future results, events, and expectations which are pursuant to the safe harbor provisions of the United States Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, those described in the company's most recent Annual Information Form and Form 20-F. Later, we will conduct a question and answer session. And please note, this conference call is being recorded. And today's date is April 27th, 2026. I would now like to turn the conference call over to Dr. Albert Friesen, Chief Executive Officer of Medicare, Inc. Please go ahead, Dr. Friesen. Thank you, Ali. And good morning to all on the call. We appreciate your interest and participation in today's call. Joining me Today, on the 2025 year-end statement, call is Horace, Medicare's Chief Financial Officer. Net revenue was $28.9 million for the year ending December 31st, 2025, compared to $21.9 million in the previous year. Net revenue was $8.5 million during the quarter, compared to $5.9 for the previous year's quarter. The company recorded a net loss for the year ending December 31st of $7.1 million, or $0.68 per share, compared to a net loss of $1 million for the year ending 2024. The net loss is due in large part to a CMS rebate liability issued to the company in th...